NCT00290693 Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00290615 Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00288002 Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer Status COMPLETED Phase PHASE3
NCT00281788 Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer Status COMPLETED Phase PHASE1
NCT00280761 Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Status COMPLETED Phase N/A
NCT00278863 Capecitabine Versus S-1 in Elderly Advanced Gastric Cancer (AGC): Randomized Trial Status COMPLETED Phase PHASE2
NCT00276744 Individualized Drug Treatment for Treating Patients With Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT00274768 Capecitabine in Treating Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00270491 Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer. Status COMPLETED Phase PHASE2
NCT00268463 Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer Status TERMINATED Phase PHASE3
NCT00268151 Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE1
NCT00266799 The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (P04445/MK-2746-071) Status COMPLETED Phase PHASE3
NCT00265733 Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00263029 Preoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal Cancer Status COMPLETED Phase PHASE2
NCT00258310 Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or Chemo Status COMPLETED Phase PHASE2
NCT00258284 Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT00258232 Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00257348 Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer Status COMPLETED Phase PHASE2
NCT00256321 Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma Status TERMINATED Phase PHASE2
NCT00254137 Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer. Status COMPLETED Phase PHASE2